- Filed
- Feb 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 14, 2025 | 113.62M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $66.16M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $1.86B |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $5.77B |
| Current Assets | FY 2024 · Dec 31, 2023 | $3.3B |
| Total Assets | FY 2024 · Dec 31, 2023 | $10.5B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 163.48M sh |
| Stock Repurchased restated | FY 2024 · Dec 31, 2022 | $2.59B |
| Capex | FY 2024 · Dec 31, 2022 | $340.15M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $3.6B |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $16.82 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $16.98 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $3.97B |
| Net Income | FY 2024 · Dec 31, 2022 | $2.75B |
| Operating Income | FY 2024 · Dec 31, 2022 | $3.77B |
| Gross Profit | FY 2024 · Dec 31, 2022 | $7.74B |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $14.98B |
| Revenue | FY 2024 · Dec 31, 2022 | $22.73B |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $4.8B |